Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

586

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Ocular HypertensionGlaucoma
Interventions
DRUG

bimatoprost 0.03% eye drops

Open-labeled latanoprost 0.005% 1 drop into each eye every evening for 6 weeks followed by a masked randomized treatment of bimatoprost 0.03% 1 drop every evening for 12 weeks

DRUG

latanoprost 0.005% eye drops

Open-labeled latanoprost 0.005% 1 drop into each eye every evening for 6 weeks followed by a masked randomized treatment of latanoprost 0.005% 1 drop every evening for 12 weeks

Trial Locations (1)

Unknown

Newport Beach

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY